Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516232 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Site LicenseAdd to Basket
EnterprisewideAdd to Basket
Electronic (PDF)Add to Basket
Live Chat Live Help Software for Website

Accelrys, Inc. (ACCL) - Financial and Strategic SWOT Analysis Review

GlobalData, Aug 2011, Pages: 42


  Description  
   Table of Contents   
   Companies Mentioned   
    
    
     
  Enquire before Buying   
  Send to a Friend   

Accelrys, Inc. (ACCL) - Financial and Strategic SWOT Analysis Review

Summary

Accelrys, Inc. (Accelrys) is engaged in the design, development, marketing and commercialization of scientific business intelligence software and solutions to enhance the discovery and development of new drugs and and processes in the biotechnology, pharmaceutical, energy, chemicals, aerospace and consumer packaged goods industries. Its software and service solutions are used by scientists, biologists, chemists and information technology professionals to aggregate, mine, integrate, analyze, simulate, manage and interactively report scientific data. The product line of the company includes, Scientific Informatics Platform, Computer Aided Design Modeling and Simulation Software and Cheminformatics Software. The company markets its products and services worldwide, principally through its direct sales force. Accelrys is headquartered at San Diego in California, the US.

Accelrys, Inc. Key Recent Developments…

Mar 03, 2011 Accelrys Reports Net Loss Of $15.6m For Q4 2010
Nov 04, 2010 Accelrys Reports Revenues Of $29.1 Million For Q2 Fiscal 2011
Aug 05, 2010 Accelrys Reports Net Loss Of $1.6 Million For Q1 2011
May 20, 2010 Accelrys Reports Net Loss Of $2.3 Million For Q4 Fiscal 2010
Apr 21, 2010 Accelrys Appoints Todd Johnson As Executive Vice President Of Sales, Marketing And Services

This comprehensive SWOT profile of Accelrys, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.



Customers who bought this item also bought

Depomed, Inc. (DEPO) - Financial and Strategic SWOT Analysis Review

Momenta Pharmaceuticals, Inc. (MNTA) - Financial and Strategic SWOT Analysis Review

Titan Medical Inc. (TMD) - Financial and Strategic SWOT Analysis Review

Hawaiian Electric Industries, Inc. -Overview, Contact Details, locations, Key executives, Power Plant Information, Business Description and SWOT Analysis

Patheon Inc. (PTI) - Financial and Strategic SWOT Analysis Review

Micromet, Inc. (MITI) - Financial and Strategic SWOT Analysis Review

MAP Pharmaceuticals, Inc. (MAPP) - Financial and Strategic SWOT Analysis Review

Array BioPharma Inc. (ARRY) - Financial and Strategic SWOT Analysis Review

SeraCare Life Sciences, Inc. (SRLS) - Financial and Strategic SWOT Analysis Review

Omnicare, Inc. (OCR) - Financial and Strategic SWOT Analysis Review



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds